	fibrin clot	10.992722218681525
	glycoprotein tissue plasminogen activator	10.123189683161792
¡°	pa circulating	9.845985740037518
¡°	human pa	9.797875178751013
¡°	recombinant human tissue plasminogen activator	8.386490280697252
	bovine fibrin plate assay	7.605086988934071
	bovine fibrin film	6.7043167279260105
	fibrin molecule	6.691383096359368
	FE1X product	5.895580049367982
¡°	human tissue plasminogen activator limitation	5.757201343347669
¡°	United States natural pa	5.6335905961682515
	human plasminogen activator limitation	5.5577779671311935
¡°	meet pa product	5.55738546835063
¡°	preferred pa standard	4.8627892854303205
	Plaintiff Leuven	1.6921073511547478
	streptokinase	1.4479027844011911
	Genetics Manufacturing	1.2136060931846802
	Leuven scientist	1.1347532148223036
	Leuven agent	1.1282718754754912
	assay standard	1.0838196889960756
	recombinant dna technology	0.9596155457119749
¡°	protein PA	0.8596134636493981
	prevail urokinase standard	0.8446168886782465
	specific assay type	0.8132806584581914
	pathological clot	0.8065750221239879
	Leuven Research Development VZW	0.780770135167278
	Genetics defendant	0.7750364326346603
	Genetics motion	0.7732352863639994
	Innovi N.V.	0.7313697933441345
	natural protein	0.655914853344004
	recombinant expression vector	0.6172844114302758
	human melanoma cell culture	0.5517585383584731
	recombinant host cell	0.513710282498612
	Inc. BW Manufacturing	0.5093896016326398
	transformed microorganism cell culture	0.503151309465864
	dna sequence	0.49719460548573985
	different route recombinant dna	0.4908014150674486
	jmol)1	0.48290955435939603
	Matsuo	0.48290955435939603
	technology.2	0.48290955435939603
	Kohr	0.48290955435939603
	Pennica	0.48290955435939603
	low affinity	0.4410949418104753
	replicable vector	0.4022939497250891
	grow recombinant cell	0.32138991333229916
	Inc. GI Manufacturing	0.32060912844588535
	Schulmerich	0.278554999088188
	Carillons	0.278554999088188
	biotechnology	0.278554999088188
	human cell	0.27849495427517723
	dissolution	0.2417365010725184
	purity	0.2417365010725184
	certain human cancer cell	0.16851040271245993
	full length amino acid sequence	0.16413495754195098
	Drs	0.16324458881376872
	naturally occur allelic variant	0.1521391804691842
	First International Reference Preparation	0.14828421560840785
	jury implied conclusion	0.1471454154910614
	thrombolytic property	0.14305497594548014
	avoidance	0.139277499544094
	McGill Inc.	0.139277499544094
	mammalian cell line	0.12521607978186278
	concert	0.11701284857277539
	Col.	0.10953420423380683
	intact vessel	0.1092542800606634
	numerical measurement	0.10621722048842892
	human body	0.10007007954004564
	particularized testimony	0.09611064557467339
	death	0.09604023055403314
	Read Corp.	0.09601284589357584
	United Kingdom	0.09285166636272933
	british counterpart	0.09152938842400886
	british court	0.08057883369083947
	MTD Products	0.08008984612772903
	IVAC Corp.	0.0735755986925688
	full length sequence	0.06727901937998805
	inactive form	0.06472827535590484
	Hormone Research Found	0.0644983036165202
	Portec Inc.	0.05850642428638769
	blood vessel	0.05394556578353147
	life threaten condition	0.05186335501693261
	Radio Steel	0.04900043728885256
	JMOL	0.048475633131373555
	relation	0.04847296629188216
	unfair competition	0.0469160695397786
	enforcement	0.04595724412274641
	forty eight minute	0.04301059861738549
	antitrust violation	0.04262688960638106
	specific activity concept	0.03542951118482385
	imply specific activity limitation	0.03273264351001165
	joint venture	0.03182053262081013
	numerical figure	0.030764544317765544
	clinically effective volume	0.029702156040865183
	prove specific activity level	0.027054463025425794
	classic issue	0.026045452424304963
	inequitable fraudulent conduct	0.024391481973384754
	heart muscle damage	0.022689295030113837
	affirmance	0.02240592621689399
	b.	0.02240592621689399
	Federal Practice	0.022204002348152826
	plaintiff appellee	0.021995364133134698
	growth medium	0.021083995969357783
	plaintiff procurement	0.020644136254671874
	less purified material	0.020211434639619854
	task	0.01922398433450915
	effectiveness	0.016040013886796333
	Delaware	0.015760812782928922
	wholly subsidiary	0.015529568436405957
	sufficient quantity	0.01484428001322625
	commercially useful quantity	0.013718453137677777
	intermediate product	0.011613098149553705
	rise	0.010989040958617892
	plausible basis	0.010981019796191102
	intended purpose	0.010960324428882541
	different entity	0.010709757558937896
	definition	0.010632138281751507
	Jr.	0.010304109966311197
	two hour	0.010266080852416409
	three threshold issue	0.009642041254633442
	threshold point	0.009626166706217465
	adverse consequence	0.009560532905204597
	additional dosage	0.009225343075981439
	undesirable side effect	0.007921442856795703
	Construction	0.007882654083082684
	plaintiff allegation	0.007606283783923861
	intention	0.00741840114353901
	representation	0.006516106100093539
	commercially useful process	0.006334977396341214
	commercially useful way	0.006333908992631785
	prejudice	0.005763209814999457
	equivalent issue	0.005666019400208975
	exclusive licensee	0.005590864506272023
	plaintiff failure	0.005556079305827297
	doctrine	0.0055347964425335365
	plaintiff case	0.0053250611053740375
	sufficient guidance	0.004301293825096582
	something	0.004052075424572792
	important role	0.0038024840534290802
	jury special verdict	0.0036773438721565627
	critical distinction	0.00334236725289133
	underlie research	0.0033077122869439243
	literal meaning	0.0032423769152233953
	development	0.0030926454002948066
	commercial demand	0.003036358345383409
	prosecution history estoppel	0.0027668593900346604
	normal amount	0.0027662699641080213
	alternative	0.0027034860309964825
	counterclaim	0.0026055300688246985
	prior art value	0.0025647744975191076
	accordance	0.002521188570568682
	literal infringement question	0.0022507505524260694
	literal infringement issue	0.002250703898326458
	affirmative defense	0.002217125642384364
	commercial production	0.0021543344672783986
	general instruction	0.0021348830229109862
	jury trial	0.002133931072620383
	August	0.0020623513880502105
	March	0.0019597212800497336
	defendant request	0.0018927185948644685
	defendant product	0.0018552003943762272
	original defendant	0.001851452904191253
	defendant motion	0.0018444741643064
	partial summary judgment	0.0016648860719914497
	different individual	0.0015755188656859315
	complaint	0.0015327007480317246
	June	0.001318945912862359
	prevail party	0.0012653471889481998
	prior work	0.0010380151312001846
	technology right	0.0010167779472319038
	proof	0.00084510130677801
	alleged infringer	0.0008371651912033264
	discovery	0.000772504488360356
	July	0.0006596610548315643
	commercial purpose	0.0006413691269624116
	complete absence	0.0006405055042113947
	sole independent	0.0006205461833836569
	none	0.0005687404518043647
	contrast	0.0005687404518043647
	trial court April	0.0005077737242620566
	cross motion	0.0005068052682021337
	substantial evidence	0.0004537694084720407
	objective	0.0003985073383355488
	October	0.00036419848065652547
	cross appeal	0.00036388717026672777
	next question	0.0003463862083339291
	prior interpretation	0.00031395305596312395
	patented product	0.0003050757083697001
	PTO	0.0002987781526981922
	know source	0.000286436023147101
	owner	0.0002564796817439352
	four separate ground	0.0002445296553587573
	great weight	0.0002240316422969636
	two accuse product	0.00017542987604890326
	general rule	0.00017317657801225276
	sufficient level	0.0001424141210922534
	ruling	0.00013879772768580047
	court denial	0.00013532847817119152
	three separate ground	0.0001298470146121856
	construction	0.00011146095032464411
	relevant portion	0.00011121921528422974
	separate action	9.731522295968067e-05
	response	6.166078858455513e-05
	suit	5.9485112556151144e-05
	favor	5.258581224389256e-05
	allege infringe product	3.7770884134486935e-05
	turn	3.660793348517177e-05
	several material	3.511285100249054e-05
	United States Patent Trademark Office	2.5614275867001093e-05
	different result	2.549474848591359e-05
	opinion	2.5356227169035172e-05
	Claim	7.393129018009041e-06
	order	6.374949663384576e-06
	subject matter	4.209848955586431e-06
	record	2.1044726003765286e-06
	Idaho	1.3391231375151548e-06
	patentee	1.1492291288317325e-06
	argument	4.828618833364835e-07
	support	4.5260481500432327e-07
	district court grant	2.0907983759028025e-07
	present appeal	2.0113516422402364e-07
	infringement action	1.586040701445563e-07
	District	0.0
	Court	0.0
	Appeals	0.0
